Clinical Trial

Transcranial Direct Current Stimulation for Post Treatment Lyme Disease

Recruiting
View on ClinicalTrials.gov →
Summary
The primary purpose of this pilot study is to investigate a novel approach to the treatment of cognitive symptoms that persist despite prior antibiotic treatment for Lyme disease (Post treatment Lyme Disease or PTLD). Aim 1: The primary aim of this study is to assess whether the processing speed of individuals with PTLD can be enhanced by combining transcranial direct current stimulation (tDCS) with computer based cognitive training games. To achieve this aim, over a 4-week period, all individuals with PTLD will participate in at home adaptive cognitive training combined with either active stimulation or sham stimulation. Aim 2: To determine if treatment benefit in processing speed is sustained, the study will compare the sham and active groups 8 weeks after completion of study treatment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-02; most recent amendment 2026-05-01.
Trial Details
NCT Number NCT06915324
Lead Sponsor Columbia University
Collaborators: Steven & Alexandra Cohen Foundation
Conditions Post-Treatment Lyme Disease
Enrollment 110 participants
Start Date 2025-07-14
Primary Completion 2027-06 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-05-06